ABSTRACT
Background. Surveys on Public Knowledge, Attitude, and Practice (PKAP) have been conducted in various countries with respondents from the public as well as health workers. Measuring the knowledge of the public about COVID-19 is very important to determine the knowledge gap among the public and also as an evaluation of the preventive efforts for COVID-19. Objective. The purpose of this research was to determine whether education level is a factor that affects one's literacy about COVID-19. Materials and Methods. This is cross-sectional research with online-based data collection using the Kobo toolbox application. The data collection was carried out from the 19th of April until the 2nd of May 2020. The number of people under study is 792. The level of knowledge was measured using 12 research questions with true or false question types. the multivariable logistic regression was carried out. Results. Most of the respondents (52.5%) were in the young age group (15-35 years old), were male (57.3%), and had a bache-lor or diploma education level (62.1%). Furthermore, most of the respondents had good knowledge (65.4%). The higher the respon-dents' educational level means, the better knowledge they had concerning COVID-19 (P=0.013). Conclusions. Public knowledge about COVID-19 is affected by their level of education. A good level of knowledge about COVID-19 was found among respondents with master's and doctoral degrees. This finding can contribute to the prevention of COVID-19, in which the priority of educating communities about COVID-19 should be given to those having an educational level below a master's degree.Copyright © the Author(s), 2023.
ABSTRACT
Introduction: Splenic rupture is a potentially life-threatening condition often associated with trauma or viral infection. Most cases of splenic rupture are due to trauma, viral infection, lymphoproliferative disease, malaria, tick borne illness, splenic neoplasms, connective tissue disease, or in one case, sneezing. Spontaneous splenic rupture (SSR) is a rare condition with less than five cases reported. In this case, we present a 20-year-old male who was seen with abdominal pain who was found to have an SSR with no clear etiology. Case Description/Methods: A 20-year-old male with no relevant past medical history presented with abdominal pain that radiated to the left shoulder. The patient reported the pain began after an episode of emesis which occurred 12 hours prior to arrival. He reported experiencing shortness of breath and pain on inspiration. He denied any fall or trauma, recent travel or sick contacts, fevers, weight loss, or night sweats. His social history was significant for occasional marijuana use. Upon physical exam, the patient had diffuse abdominal tenderness most pronounced in the left upper quadrant without any palpable masses. Relevant labs included a hemoglobin of 12.2, WBC count within normal limits and unremarkable manual differential, and an INR of 1. Blood parasite, heterophile antibodies, COVID, influenza, CMV, and HIV were negative. Computed tomography angiography (CTA) revealed hematoma at the splenic hilum. Interventional radiology was consulted and did not recommend intervention at time of initial presentation. Patient was admitted;his hemoglobin remained stable and he was monitored with serial abdominal exam then discharged the following day. Imaging was repeated one month later which revealed near complete resolution of hematoma. (Figure) Discussion: SSR should be considered on the differential diagnosis of physicians when encountering patients who present with LUQ pain with unclear etiology. The patient presented with the characteristic Kehr's sign (left diaphragmatic irritation resulting in referred pain to the left shoulder) but not the Ballance sign (palpable tender mass in the left upper quadrant). The incidence of SSR is estimated to be around 1 to 7% with a mortality rate of 12.2% so a broad differential for young patients presenting with abdominal pain must be entertained and should include splenic rupture as it is a potentially life-threatening condition.
ABSTRACT
Background: We performed a search in the PubMed databases, Web of Science, LILACS, MEDLINE, SciELO, and Cochrane Library using the keywords COVID-19, Novel coronavirus, corona, 2019-nCoV, SARS-CoV-2, ENT, nose, anosmia, hyposmia, smell, olfactory, ORL, different ENT related symptoms. We reviewed published and peer-reviewed studies that reported the ENT manifestations in COVID-19 laboratory-confirmed positive patients. Main text: Within the included 2549 COVID-19 laboratory-confirmed positive patients, smell affection was reported in 1453 patients (57%). The other reported ENT manifestations were taste disorder (49.2%), headache (42.8%), nasal blockage (26.3%), sore throat (25.7%), runny nose or rhinorrhea (21.3%), upper respiratory tract infection (URTI) (7.9%), and frequent sneezing (3.6%). Conclusion(s): Smell affection in COVID-19 is common and could be one of the red flag signs in COVID-19 infection. With a sensitivity of utilized questionnaire in smell identification, a homogenous universal well-defined COVID-19 questionnaire is needed to make the COVID-19 data collection more sensible.Copyright © 2021, The Author(s).
ABSTRACT
Coronavirus disease 2019 (COVID19) is the recently reported disease caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID19 spreads among population through the close/direct contact and nasal droplets when an infected person sneezes, coughs, talks or breaths. On an average, COVID19 infected patient develops clinical symptoms 5-6 days after the infection and some develops symptoms even after 14 days of infection. Detailed study on the symptoms shown by COVID19 patients can help in identifying individuals so that proper identification and isolation of patients can be done and transmission of virus can be reduced significantly. In this study, a total of 99 (66 males and 33 female) COVID19 infected symptomatic patients without any comorbidities were included. Nasopharyngeal and oropharyngeal swabs were used for the collection of samples from the suspected patients to extract total RNA and perform real time PCR for the detection of genetic material for SARS-CoV-2. Samples with Ct value = 36 in case of Orf1ab gene and E gene with good sigmoidal curve were reported as positive for novel SARS-CoV-2. Fever, shortness of breath, dry cough and cough with sputum production persisted for longer timer and were more common symptoms reported by the COVID19 infected patients. In conclusion, understanding of the clinical symptoms shown by COVID19 infected patients can help in identification and isolation of patients so that transmission of virus can be reduced significantly.
ABSTRACT
The COVID-19 outbreak has fashioned to severe threat to each and every individual in social and economic aspects in the country. This required improved wisdom to know how it is different and dominant, to diagnose and determine effective vaccines to avoid the transmission of these deadly causative agents. From this review, the probable property of these deadly transmissible viruses is related to that of SARS-CoV-2 as a fright zone of viruses. It also provides some sparks about effective and accurate diagnosis and treatment strategies. The effective management and control of panic zone of virus (PZV) and SARS-CoV-2 are more important to reduce the pandemic situation.Copyright © 2023 Inderscience Enterprises Ltd.
ABSTRACT
Coronavirus disease is a contagious respiratory ailment that has spread significantly around the world. Most cases of COVID-19 are spread from person to person by coming into contact with respiratory droplets that are released when an infected person coughs or sneezes. In this manuscript, we have highlighted the possible transmission of COVID-19 through food, water, air and paper. In the case of food, we have extensively covered the transmission of COVID-19 through meat, frozen foods, food packaging and food market along with the incidences worldwide. In the nextsection, we have highlighted the different components of air which are responsible for the transmission and also covered its relation with PM 2.5 incidence. The SARS-CoV-2 was isolated from sewage water/wastewater of various countries namely the United States, India, Australia, Netherlands and France signifying that wastewater can be a mode of virus transmission. The paper circulation by the infected COVID-19 patients can also be a virus conveyance route. It can be concluded that SARS-CoV-2 can therefore be transmitted indirectly through food via the workers involved in food packing or food marts.By following general safety precautions (wearing masks, using hand sanitisers, cleaning and disinfecting contact surfaces, and avoiding close contact), heating and using chemicals like ethanol (67-71%), sodium hypochlorite (0.1%) and hydrogen peroxide (0.5%) on environmental surfaces, along with vaccination, it is possible to reduce the spread of the SARS-CoV-2 virus.Copyright © 2023 The International Journal of Pharmaceutical Research and Allied Sciences (IJPRAS).
ABSTRACT
As we know novel coronavirus is an emergent nuisance in this stipulated period. Corona virus is a group of enveloped viruses, with non-segmented, single stranded & positive sense RNA genomes. Human Corona virus is mainly subdivided into four categories such as 229E, NL63, OC43, HKU1. Epidemiologically it has a greater prevalence in the modern era. The features encountered in the clinical course of the disease are multifarious spanning from cough, sneezing, fever, breathlessness. It may take 2-14 days for a person to notice symptoms after infection. Azithromycin and 8 Hydroxychloroquine both plays an instrumental role for management of COVID-19. Azithromycin is a macrolide antibiotic and it binds with a 50s ribosome then inhibits bacterial protein synthesis. On the other hand 8-Hydroxychloroquine was approved by United State in the year of 1955 .Basically it is used as a antimalarial drugs . Briefly, in inflammatory conditions it binds with toll like receptor & blocks them. 8- hydroxychloroquine increases lysosomal pH in antigen presenting cells . In inflammatory conditions it blocks toll like receptors on plasmacytoid dendritic cells. In our review we focused on the role of Azithromycin, and 8-hydroxychloroquine in Covid-19 .Copyright © 2021 International Journal of Pharma and Bio Sciences. All rights reserved.
ABSTRACT
COVID-19 may be a very contagion caused by a recently discovered called corona virus. Novel corona virus was found in December 2019 in Wuhan, China. World Health Organization has declared the COVID-19 as pandemic disease and outbreak as a health emergency globally. Novel Corona Virus is additionally referred to as severe acute respiratory syndrome corona virus- 2. The foremost infected people with corona virus show commonly respiratory illness like- fever, cold, sneezing, cough, pneumonia, upper respiratory illness, GIT disease like nausea, vomiting as symptoms. Recently published evidences stated that light Fever and cough within the 80 % patients, shortness of breath in 30-35% patients and 10-15% patients show Muscle ache and other ache. Novel Corona virus enters through the membrane ACE-2 receptor within the human cell. Corona virus is spherical or pleomorphic, single stranded, enveloped ribose macromolecule and included club shaped glycoprotein. SARS, Respiratory (breathing) infections are often transmission via droplets of various diameter like >5-10 micrometer. Molecular test administered with respiratory samples, like throat swab, sputum and broncholveolar lavage and in some severe cases it reported in stool and blood also. After the WHO and other diagnostic guideline said that the PCR and RT-PCR test reported for corona diagnosis.Copyright © 2022 Dr. Yashwant Research Labs Pvt. Ltd.. All rights reserved.
ABSTRACT
Despite the gradual return to pre-pandemic conditions, the spreading of COVID-19 (SARS-CoV-2) left several open issues. Nowadays it is know that airborne infections, including COVID-19, are conveyed by particles having the size of >5 mum (droplets) and <5 mum (droplets nuclei), ejected by coughing and sneezing [1]. While droplets undergo to dehydration and precipitation, droplet nuclei persist in air for long time after their ejection, contributing to infection spreading. Actual prevention strategies are based on non-pharmaceutical interventions act to reduce droplets diffusion and spacing from Personal Protective Equipment, such as facial masks, and social distancing measure. Nevertheless, for the new endemic phase of COVID-19 the development of new strategies for airborne infections' containment becomes unavoidable. In this project, we propose a new device for the suppression of Airborne Viral Aerosols designed to work in situations with constrained geometries (e.g. public transportation, offices, waiting rooms etc.) not allowing social distancing. The device, devised to perform photokilling of viral aerosols in air in presence of humans, has its core in an UV illumination system operating at 222 nm. It is know from literature that UV radiation alters the genetic material of viruses and bacteria whose maximum absorption wavelengths are in the far-UV range (UVC, 100-280 nm), the most effective for sterilization [2]. Differently from the operative wavelength of most commercial systems (254 nm), the higher tissue absorption prevents the 222 nm radiation to travel over the very first epidermal layers [3] constituting a minor health risk for applications in presence of people. The device combines the UV illumination system with a vertical flux of air that conveys exhaled particles to the light source and controls humidity and temperature, crucial parameters for virus diffusion. After its development, the device prototype will be tested in model experiments. Initially, its safety will be verified by monitoring in particular the UVC-induced ozone production. Then, in vitro photokilling experiments will be performed in two steps: (i) on a layer of immobilized SARS-Cov-2 virus act to obtain optimal UV doses for an effective sterilization;(ii) on SARS-Cov-2 aerosol models. For this last experiment, a model viral aerosol miming the characteristics of cough and sneeze particles will be preliminary studied and supported by synthetic data to characterize the optical properties of the reference scenario. The resulting information will be crucial for the final design of the device itself. As a last step, we will test the device in in vivo experiments. An air flux, harvesting exhaled air by infected mice, will be illuminated by the device and will be sent to healthy mice. Finally, the infectiveness of exhaled air after the UV treatment will be evaluated, providing more information for further applications in the presence of humans.Copyright © 2023
ABSTRACT
The COVID-19 pandemic is raging across the globe, with the total active cases increas-ing each day. Globally over 63 million COVID-19cases and more than 1.4 million deaths have been reported to WHO. Throughout the world, academicians, clinicians and scientists are working tirelessly on developing a treatment to combat this pandemic. The origin of novel SARS-CoV-2 virus still remains foggy but is believed to have originated from a bat coronavirus RaTG13 with which it shares approximately 96% sequence similarity. In the present review, the authors have pro-vided an overview of the COVID-19 pandemic, epidemiology, transmission, developments related to diagnosis, drugs and vaccines, along with the genetic diversity and lifecycle of the SARS-CoV-2 based on the current studies and information available.Copyright © 2022 Bentham Science Publishers.
ABSTRACT
Food safety remains a major issue around the world particularly when the COVID-19 pandemic becomes the main issue nowadays. Food safety is essential to the human population worldwide because food is the primary energy source and nutrition for humans. Therefore, food handlers' personal hygiene is one of the factors that are necessary to maintain food safety. The purpose of this study was to assess the food handler's compliance with personal hygiene practices in randomly any food outlets across Malaysia including Kuching, Sarawak;Lawas, Sarawak;Johor Bahru, Johor;Kuala Penyu, Sabah, and Gurun, Kedah. A quantitative method, a cross-sectional descriptive study to one thousand and five (N = 1005) food handlers who participated in the questionnaire and observation checklist was developed by modifying questions in accordance with the Food Hygiene Regulations 2009. Overall, the mean percentage of conformity in adhering to food handler attire was the highest observed at Gurun, Kedah and Kuala Penyu, Sabah with 86.96% and 80.79%, respectively, followed by Kuching, Sarawak with 77.5%, Johor Bahru with 76.71%, and Lawas, Sarawak with 74.93%. Personal hygiene practices conformity showed a high mean percentage with all districts scoring >91% higher than non-conformity. The food handlers also show less unhygienic behaviour while on duty and scored a mean percentage of > 92%. Although in that positive behaviour, some of the food handlers did not perform some unhygienic practices (<= 8 %). In conclusion, there is no significant difference (p-value > 0.05) in the level of conformity between the mean percentages among all districts. Thus, this issue shall raise a concern to the food industries in order to make sure their workers comply with the legal requirement and to avoid any food poisoning outbreak related to food hygiene and food safety in the future.Copyright © 2023 The Authors.
ABSTRACT
Introduction: Attributable to the difficulties in specimen collection, discomfort and symptoms caused on by Nasopharyngeal (NPS) and Oropharyngeal Swab (OPS) collection, and significant risk to Healthcare Workers (HCW), evaluation of an alternative specimen for the diagnosis of Coronavirus Disease 2019 (COVID-19) is required. Saliva specimen could be an alternative specimen with many advantages over NPS and OPS, however little is known about how well it performs this purpose. Aim(s): The present study was conducted to assess the efficacy of saliva as a viable and simple alternative specimen to NPS and OPS for COVID-19 Real-Time reverse transcriptase Polymerase Chain Reaction (rRT-PCR). Material(s) and Method(s): The present cross-sectional study was conducted in the Department of Microbiology, SGT Medical College Hospital and Research Institute, Haryana, India, from July 2020 to December 2020. A total of 60 symptomatic and 20 asymptomatic COVID-19 patients were recruited for the study and specimen viz., saliva, NPS and OPS were collected at four different sampling points i.e., on day 1, 5, 7 and 14 after confirmation of COVID-19 rRT-PCR test positivity. Data obtained from the study was analysed and expressed as median, frequency, interquartile range and Chi-square test was done for comparison of categorical variables. Result(s): Majority of the patients in symptomatic hospitalised COVID-19 patients were males (n=49, 81.7%) and remaining were females (n=11, 18.3%) and in asymptomatic group 8 (40%) were males and 12 (60%) were females. Saliva was the most sensitive specimen (74.2%), followed by NPS, Naso Oropharyngeal Swab (NOPS) with 70.8% each and OPS (65.8%) for detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in symptomatic patients at four different sampling points. Comparable findings were also observed in specimens obtained from asymptomatic individuals as well. In addition, the viral load was also highest in saliva sample, as measured by Cycle Threshold (CT)-value. Across all specimen types, high viral load (lower CT-values) was observed during the early period of infection. Majority of the study participants reported discomfort during NPS and OPS collection (90% and 85%, respectively), lacrimation, sneezing and gag reflex being the most commonly reported induced symptoms. Conclusion(s): In the present study, saliva could be a viable and alternate specimen for COVID-19 diagnosis due to its ease in sample collection, specimen stability and reduced risk of transmission of infection due to droplets.Copyright © 2023 Journal of Clinical and Diagnostic Research. All rights reserved.
ABSTRACT
The outbreak of coronavirus disease 2019 (COVID-19) was first reported in Wuhan, Chi-na, and soon the infection turned into a pandemic. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the spread of COVID-19 infection. The World Health Organization (WHO) confirmed 4.20% of total deaths globally (March 21, 2020). Within four months (July 21, 2020), the rate of confirmed total deaths was recorded up to 4.17% globally. In India, 909 confirmed cases and 19 deaths were reported by Health and Family Welfare, Government of India, on March 28, 2020. Over a period of 123 days in India, 1638870 confirmed cases and 35684 deaths were reported. COVID-19 can potentially spread from person to person through direct contact or respiratory droplets from coughing and sneezing. The most common symptoms are fever, dry cough, difficulty in breathing, and fatigue. A pregnant mother with COVID-19 has fewer chances of trans-ferring this infection to her newborn baby. Children are less affected than adults from this virus. A specific antiviral drug or vaccine has not been developed to cure the disease to date. Drugs including chloroquine, hydroxychloroquine, lopinavir, ritonavir, nafamostat, nitazoxanide, and remde-sivir, have been observed to be effective for treating COVID-19. Many vaccine candidates are under investigation in pre-clinical and clinical studies. In this review, we highlight the epidemiology, signs and symptoms, pathogenesis, and mode of transmission of the infection caused by COVID-19, and its effects on a pregnant mother and newborn, and children. We also highlight the preventive measures and drugs that are effective for treating COVID-19.Copyright © 2021 Bentham Science Publishers.
ABSTRACT
Coronavirus disease 2019 (COVID-19), named by WHO, is a real public health disaster of the third millennium. This highly contagious viral disease has infected the world population and is now a global pandemic. This acute respiratory distress syndrome (ARDS) has severe complica-tions like pneumonitis, respiratory failure, shock, multiorgan failure, and death. Well-defined FDA-approved synthetic is not yet available. Case management strategies like lockdown, use of masks and sanitizers, social distancing, and repurposing of antiviral drugs were initially undertaken to cope with this pandemic. Different broad-spectrum antiviral drugs are being repurposed as one of the treatment modalities. The global vaccination programme with the newly launched COVID-19 vac-cines, Covishield, covaxin, sputnik V, etc., is an ongoing process. Simultaneously, significant research is being carried out in search of natural antivirals and evaluating the potency of food bioac-tives to aid naturistic protection against the coronavirus. This mini-review has compiled the latest updates on the screening and evidence-based mechanistic evaluation of phytochemicals and food bioactives as non-pharmacological adjuvant aid in COVID pandemics.Copyright © 2023 Bentham Science Publishers.
ABSTRACT
Background: Coronavirus disease (COVID-19) is spreading rapidly at an unprecedented scale across continents and has emerged as the single biggest risk the world has faced in modern times. Some scientists are comparing it to Spanish flu that created havoc around a century ago. The fear of death by COVID-19 looms large in the world today. The disease has reached devastating proportions since its first reports in December 2019. Doctors are having a difficult time dealing with this challenge and the microbiologists are having sleepless nights to bring about an effective vaccine for this disease. Method(s): A number of research and review articles have been exhaustively reviewed. The collected data has been meticulously analyzed and documented. Conclusion(s): This paper reviews the different types of coronaviruses, the structure of SARS-CoV-2 re-sponsible for COVID-19, its transmission, and virulence. Further, the article discusses the diagnosis, signs and symptoms like fever, breathlessness, cough, potential loss of taste or smell, sneezing, runny nose, fatigue, headache, sore throat and different treatment approaches including drug repurposing being tried by doctors around the globe that may come handy in the management of disease symptoms. The article describes the use of remdesivir, ribavarin, lopinavir, favipiravir, hydoxychloroquine, chloroquine, and tocilizumab among others in treating COVID-19.Copyright © 2021 Bentham Science Publishers.
ABSTRACT
A better understanding of the fluid dynamics of disease transmission by disintegrated respiratory droplets has been the focus of great attention since the recent outbreak of COVID-19. In particular, human respiratory activities such as coughing, sneezing and even talking and eating expel a large amount of pathogen-laden droplets. Particularly, during eating or drinking, the physical properties of saliva can be changed. In this study, we investigate the atomization morphology of expelled artificial saliva mixtures from the perspective of varying fluid physical properties, specifically surface tension and dynamic viscosity. Using high-speed shadowgraph experiments on artificial saliva, we visualize and analyse the disintegration of saliva liquid sheets into ligaments and droplets. We find that the viscosity and surface tension affect the droplet size formed from expelled saliva and follow scaling laws that have been previously observed and predicted for constant shear viscosity. We conclude that the changes in physical properties of saliva induced by eating and drinking tend to favour the formation of smaller droplets during sneezing or coughing, which could drive the airborne transmission pathway of pathogens. Furthermore, we derive a theoretical model based on scaling arguments that shows the breakup time of ligaments produced from the artificial saliva mixtures is dependent on the capillary number.
ABSTRACT
Statins, which are widely used to treat hypercholesterolemia, have anti-inflammatory and antioxidant effects, upregulate angiotensin-converting enzyme 2 (ACE2) receptors, which happen to be SARS-CoV-2's gateway into cells. This study aims to analyse the effects of Fenofibrate in comparison to Statins and a control group in patients with COVID-19. This is a retrospective open blind observational study of cohort of 300 patients experienced COVID-19 (symptoms' severity varied between patients). The participants were divided into three cohorts;a control group received standard COVID-19 treatment (n=100);a second group (n=100) of patients who were on Statins, in addition they received the standard treatment;and a third cohort for patients who were already taking Fenofibrate (TRICORR) as a medication to treat hyperlipidemia (n=100). Most symptoms (including cough, exertional dyspnoea, SOB, sore throat, sneezing, headache, tiredness, agitation, diarrhoea, joint pain, insomnia, myalgia, and fatigue) were less prevalent for patients who administered antihyperlipidemic drugs compared to the control group. Patients who were already taking Cholesterol-lowering medication presented with symptoms varied between mild to severe. Patients on Statins or Fenofibrate also showed less tachycardia and tachypnoea compared to those who were not on antihyperlipidemic drugs, and also the need for oxygen and ICU admission were less frequent. The length of stay in hospital was shorter in patients who were already on Statins or Fenofibrate. Both Statins and Fenofibrate have improved the outcome and the severity of symptoms for patients with Covid 19 infection.